StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Luckey 13

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jul 25, 2024 4:21pm

73 Views

Post# 36148730

RE:RE:Luckey 13

You want a real chuckle try the Care book a session chatline.

WillHey wrote: I just tried calling the phone number on their website. I guess they must be so busy no one can take my call in customer services and I have to leave a message.

haha

nope they just dont have anyone employeed to pick up the phone. Why pay someone to do something that they never have to do because they have no customers.

the only revenue they have and have been killing is that left over from Care Oncology.

Q2 for 2024 will be under $300K in revenue. Care Oncology used to make a million a quarter according to past news releases.